1. AAV8-mediated CasRx delivery and expression in the cochlea and cochlear nucleus of mice
Zhou S, Huang T, Yao W, Huang S, Jiang J, Liao H, Et Al.
CRISPR/Cas9-based genome editing has made substantial progress in recent years and has enabled the treatment of a variety of genetic diseases, including hearing loss in congenitally deaf mice. However, successful gene editing for hereditary deafness may still induce off-target mutations in genomic DNA, which limits…
Read the article